Skip to content
Back to announcement

20240502_KLBF_Laporan Informasi dan Fakta Material_31633492_lamp1.pdf

Other Text extracted KLBF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1 OCR 0.921
@ kate

Jakarta, 02 Mei 2024 / May 02, 2024
No. 023/CSEC-KF/V-2024

Kepada Yth.

Lt. Dewan Komisioner Otoritas Jasa Keuangan

Board of Commisioner of Financial Services Authority

Gedung Soemitro Djojohadikusumo
Jl. Lapangan Banteng Timur No. 2-4
Jakarta 10710

u.p./Attn. : Kepala Eksekutif Pengawas Pasar Modal
Executive Head of Capital Market Supervisory
2. PT Bursa Efek Indonesia

Gedung Bursa Efek Indonesia

Indonesia Stock Exchange Building Tower I, 6" Floor

Jl. Jend. Sudirman Kav. 52-53
Jakarta 12190
u.p./Attn. : Direksi

Board of Directors

Perihal/
(“Perseroan”)
Subject
(“Company”)

Dengan hormat,

Merujuk pada surat kami tertanggal 09 Juni 2023
No. 037/CSEC-KF/VI-2023 perihal Perpanjangan
Waktu Pengalihan Saham Hasil Pembelian
Kembali, bersama ini Perseroan berencana untuk
mengalihkan saham hasil pembelian kembali
tersebut dengan cara penjualan melalui Bursa
Efek Indonesia.

Berdasarkan Pasal 35 Peraturan Otoritas Jasa
Keuangan (POJK) No. 29 Tahun 2023 tentang
Pembelian Kembali Saham yang Dikeluarkan
oleh Perusahaan Terbuka, Perusahaan Terbuka
wajib mengumumkan keterbukaan informasi
kepada masyarakat dan menyampaikan
dokumen pendukungnya kepada Otoritas Jasa
Keuangan paling lambat 5 (lima) hari kerja
sebelum mulainya periode pelaksanaan
penjualan saham hasil pembelian kembali.

PT. KALBE FARMA Tbk.
Head Off

Pengalihan Saham Hasil Pembelian Kembali Saham PT Kalbe Farma Tbk

Transfer of Shares Resulting from Shares Buyback of PT Kalbe Farma Tbk

Dear Sirs,

Referring to our letter dated on June 09, 2023
No.  037/CSEC-KF/VI-2023  regarding — the
Extension of Time for the Transfer of Buyback
Shares, in relation to that the Company plans to
transfer the shares resulting from the buyback by
selling through the Indonesian Stock Exchange.

Based on Article 35 of the Financial Services
Authority Regulation (POJK) No. 29 of 2023
concerning the Buyback of Shares Issued by
Public Company, the Public Company is obliged
to announce information disclosure to the public
and submit supporting documents to the
Financial Services Authority no later than 5 (five)
working days before the start of the period
selling shares resulting from the buyback.

: Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4, Jakarta 10510, PO. Box 9105 JAK, Jakarta, Indonesia. Tel. (021) 42873888-89 Fax. (021) 42873680

Factory : Kawasan Industri Delta Silicon, Jl. M. H- Thamrin Blok A3 - 1, Lippo Cikarang, Bekasi 17550, PO.Box371 Bekasi 17037, Indonesia,

Tel. (021) 89907338 Fax. (021) 8972874 inlo@kalbe.coid
Page 2 OCR 0.921
@ kause

Melalui surat ini Perseroan berencana untuk
mengalihkan saham hasil pembelian kembali
melalui Bursa Efek Indonesia, dengan
informasi sebagai berikut:

1. Perseroan menunjuk PT Samuel Sekuritas
Indonesia untuk melakukan pengalihan
saham:

2. Waktu pelaksanaan saham sejak tanggal
13-15 Mei 2024,

3. Jumlah saham yang akan dialihkan sebanyak
2.175.000 (dua juta seratus tujuh puluh lima
ribu) lembar saham dengan memperhatikan
peraturan terkait.

Terima kasih atas perhatian dan kerjasamanya.

Hormat kami/Sincerely,
PT Kalbe Farma Tbk

Maria Teresa Fabiola
Corporate Secretary

PT, KALBE FARMA Tbk.

With this letter, the Company plans to transfer
the shares resulting from the buyback through
the Indonesia Stock Exchange, with the following
information:

1. The Company appoints PT Samuel Sekuritas
Indonesia to assist on the transfer of those
shares,

2. Stock transfer exercise time is starting from
13-15 May 2024,

3. The number of shares to be transferred
2,175,000 (two million one hundred seventy
five thousand) shares taking into account the
relevant regulation.

Thank you for your attention and cooperation.

Head Office : Gedung KALBE, Jl. Let. Jend, Suprapto Kav. 4, Jakarta 10510, PO. Box 3105 JAK, Jakarta, Indonesia. Tel. (021) 42873888 -89 Fax. (021) 42873680
Factory : Kawasan Industri Delta Silicon, Jl. M. H. Thamrin Blok A3 - 1, Lippo Cikarang, Bekasi 17550, RO.Box 371 Bekasi 17037, Indonesia.

Tel. (021) 89907333 Fax. (021)8972874 inio@kalbo.co,id

File

File Open PDF
Source IDX
Size0.59 MB
Published2 May 2024
Pages2
Characters4,001
Text sourceOCR
OCR confidence0.921

Names mentioned 9 people and organisations named in the text · linked when the evidence is strong

linked org KALBE FARMA Tbk. p.1 ×13
linked org Lippo Cikarang p.1 ×2
possible org Otoritas Jasa Keuangan p.1 ×3
possible org PT Bursa Efek Indonesia p.1 ×4
possible org PT Samuel Sekuritas Indonesia p.2 ×3
unresolved org Financial Services Authority p.1 ×3
unresolved org Indonesia Stock Exchange p.1 ×2
unresolved person Maria Teresa Fabiola · Corporate Secretary p.2
unresolved person H. Thamrin p.2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 1

↑↓ select ↵ open ⇧↵ see every result